This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INDEPENDENT_MULTIPLE_SITES_NAS_EXALLC for full statistics.
Malignant neoplasms of independent (primary) multiple sites
CD2_INDEPENDENT_MULTIPLE_SITES_NAS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
20 |
4. Check minimum number of eventsNone |
20 |
5. Include endpointsNone |
20 |
6. Filter based on genotype QC (FinnGen only) |
20 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- C97-C97
- Name in latin
- Neoplasmata maligna locis multis non dependentibus (primariis)
Similar endpoints
↥List of similar endpoints to
Malignant neoplasms of independent (primary) multiple sites
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasms of independent (primary) multiple sites
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 20 | 8 | 12 |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | 0.01 |
| Median age at first event (years) | 59.50 | 45.23 | 69.01 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
10
34
4.88
2.90
5.9
3.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
10
38
4.26
2.45
2.2
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
6
18
4.29
1.91
5.2
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
6
18
4.29
1.91
3.3
1.7
%
16.2
29.6
—
6
18
(3022948) Iron [Moles/volume] in Serum or Plasma
6
19
4.04
1.82
3.5
1.6
umol/l
7.7
15.6
—
6
19
(3004789) Transferrin [Mass/volume] in Serum or Plasma
6
20
3.82
1.73
3.5
1.6
g/l
1.7
2.3
—
6
20
(3042936) Bacteria identified in Isolate by Culture
6
20
3.82
1.73
3.8
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
8
132
0.35
1.55
6.4
4.6
mu/l
2.0
2.0
—
8
126
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
6
23
3.27
1.50
2.0
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5
18
3.34
1.37
1.8
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5
19
3.15
1.30
2.0
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
5
19
3.15
1.30
3.0
4.1
mmol/l
1.2
1.0
—
5
19
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
6
108
0.37
1.23
5.5
4.0
pmol/l
13.6
15.0
—
6
103
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
8
48
2.10
0.76
1.6
2.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
10
65
2.08
0.73
5.3
5.6
mmol/l
1.2
1.2
—
10
57
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
9
66
1.66
0.49
4.3
3.3
—
—
—
0
0
(3013512) EKG study
5
34
1.62
0.44
4.0
3.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
15
0.00
0.43
0.0
2.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
6
43
1.56
0.40
21.8
6.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
7
50
1.61
0.38
2.6
2.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
10
78
1.56
0.33
7.3
5.3
mmol/l
8.0
6.7
—
10
72
(3009542) Hematocrit [Volume Fraction] of Blood
14
120
1.55
0.32
23.8
14.5
%
30.0
40.2
—
8
93
(3037467) Urinalysis macro (dipstick) panel - Urine
11
91
1.46
0.31
9.5
3.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
5
37
1.47
0.26
1.2
2.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
6
46
1.43
0.24
9.0
4.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
6
48
1.36
0.23
3.0
1.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
6
48
1.36
0.23
6.8
3.1
—
—
—
0
0
(3015736) pH of Urine
6
50
1.28
0.22
7.2
2.7
—
—
—
0
0
(3000492) Spirometry study
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
11
0.00
0.22
0.0
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
11
0.00
0.22
0.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
9
101
0.80
0.09
3.2
3.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.3
—
4.1
—
0
7
(3003338) MCHC [Mass/volume]
12
120
1.00
0.00
32.1
17.2
g/l
330.9
333.1
0.29
12
120
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.4
—
69.2
—
0
5
(3001019) Free T4 and TSH panel - Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
0
6
0.00
0.00
0.0
8.7
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
0
5
0.00
0.00
0.0
3.4
—
4.4
—
0
5
(40768443) Skin Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
9
89
1.02
0.00
4.0
3.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
13
130
1.00
0.00
4.2
4.3
mmol/l
6.1
5.9
0.19
13
125
(3027315) Oxygen [Partial pressure] in Blood
0
5
0.00
0.00
0.0
3.4
—
8.4
—
0
5
(3009214) Lutropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
7.1
—
0
7
(3003327) Ova and parasites identified in Stool by Light microscopy
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
6
64
0.91
0.00
14.8
7.3
e9/l
0.0
0.0
—
6
52
(40768800) Prostate Pathology biopsy report
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INDEPENDENT_MULTIPLE_SITES_NAS – Malignant neoplasms of independent (primary) multiple sites
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).